2025 annual financial data
Aptevo Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -26,312,000 USD and net income was -25,967,000 USD.
Operating cash flow was -25,592,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,312,000 USD
- Net income
- -25,967,000 USD
- Operating cash flow
- -25,592,000 USD